Warning
Possible tax debts
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 0 € | 0 € | 0 € |
Profit | - | - -100.0% | 528,7k € +68.9% |
Assets | - | - | - |
Liabilities | - | - | - |
Equity | - | - | - |
Employees | - | - | - |
Overall rating | B65/100 |
Financial health | 50/100 |
Credit history | 70/100 |
Legal history | 85/100 |
Business activity | 60/100 |
| Overall risk | Medium |
Possible tax debts | |
Possible tax debts | |
No financial data available | |
Regular report filing | |
| Description | Registered |
|---|---|
| Board |
| Description | Registered |
|---|---|
| CEO (Male) |
UAB "Novo Nordisk Pharma" is located at Vilnius, Šeimyniškių g. 19C-801, LT-09236, LT-LT-09236.
The shareholders of UAB "Novo Nordisk Pharma" include 1 Lithuanian legal entities. View ownership details →
Yes, UAB "Novo Nordisk Pharma" is registered as an active VAT payer with VAT number LT100001731013.
UAB "Novo Nordisk Pharma" was founded on May 12, 2005. The company has been operating for 21 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 21 years | - | 0% | |
Registered capital | 193 500,00 € | - | 90% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Annual financial report for 2019.
Registered in the Lithuanian register of legal entities.